Related Experiment Video
Updated: May 23, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly
Christopher C Valley1, Andrew K Lewis, Deepti J Mudaliar
1Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Abstract:
Recent evidence suggests that TNF-related apoptosis-inducing ligand (TRAIL), a death-inducing cytokine with anti-tumor potential, initiates apoptosis by re-organizing TRAIL receptors into large clusters, although the structure of these clusters and the mechanism by which they assemble are unknown. Here, we demonstrate that TRAIL receptor 2 (DR5) forms receptor dimers in a ligand-dependent manner at endogenous receptor levels, and these receptor dimers exist within high molecular weight networks. Using mutational analysis, FRET, fluorescence microscopy, synthetic biochemistry, and molecular modeling, we find that receptor dimerization relies upon covalent and noncovalent interactions between membrane-proximal residues. Additionally, by using FRET, we show that the oligomeric structure of two functional isoforms of DR5 is indistinguishable. The resulting model of DR5 activation should revise the accepted architecture of the functioning units of DR5 and the structurally homologous TNF receptor superfamily members.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers cell death by forming DR5 receptor clusters. This study reveals DR5 receptor dimers form via membrane-proximal interactions, revising models of TRAIL-mediated apoptosis.
Area of Science:
- Molecular and Cellular Biology
- Immunology
- Biochemistry
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine with potential anti-tumor activity.
- TRAIL initiates apoptosis by inducing the clustering of its receptors, but the precise structure and assembly mechanisms remain unclear.
Purpose of the Study:
- To elucidate the structural organization and assembly mechanism of TRAIL receptor 2 (DR5) clusters.
- To investigate the role of receptor-ligand interactions in DR5 dimerization and network formation.
Main Methods:
- Ligand-dependent receptor dimerization was assessed at endogenous levels.
- High molecular weight networks were analyzed using FRET, mutational analysis, fluorescence microscopy, synthetic biochemistry, and molecular modeling.
- Oligomeric structures of DR5 isoforms were compared using FRET.
Main Results:
- DR5 forms receptor dimers in a ligand-dependent manner.
- These dimers are part of larger, high molecular weight networks.
- Receptor dimerization is mediated by covalent and noncovalent interactions involving membrane-proximal residues.
- Two functional DR5 isoforms exhibit indistinguishable oligomeric structures.
Conclusions:
- DR5 activation involves the formation of receptor dimers stabilized by membrane-proximal interactions.
- The findings propose a revised model for DR5 functioning within the TNF receptor superfamily.
- This work advances the understanding of TRAIL-mediated apoptosis signaling pathways.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
